Ledger.Open graph →

SEC Form D · filed April 11, 2025

Lytica Therapeutics, Inc

Offering

—

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Daniel Macaya · CAMBRIDGE, MADirector Jean-Francois Ducrest · CAMBRIDGE, MADirector James Latorre · CAMBRIDGE, MADirector Rida Mourtada · CAMBRIDGE, MAExec · Director Rida Mourtada · CAMBRIDGE, MAExec · Director Daniel Macaya · CAMBRIDGE, MADirector James Latorre · CAMBRIDGE, MADirector Jean-Francois Ducrest · CAMBRIDGE, MADirector Glenn Argenbright · Aventura, FLDirector Ronald Buschur · Aventura, FLDirector Maynard Hellman · Aventura, FLExec · Director Nelson E. Lamis · Aventura, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗